☆ 4.2 Article

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia

TRANSPLANTATION AND CELLULAR THERAPY (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Biophysics

Autologous hematopoietic cell transplantation during second or subsequent complete remission of acute promyelocytic leukemia: a prognostic factor analysis

Masamitsu Yanada et al.

Summary: Autologous hematopoietic cell transplantation is effective for patients with relapsed acute promyelocytic leukemia, with very favorable long-term results when conducted during CR2+. Other factors such as age, disease status, and MRD status did not predict survival outcomes.

BONE MARROW TRANSPLANTATION (2022)

添加到收藏夹

Article Biophysics

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012

Cinthya Correa et al.

Summary: The survey results from Latin America in 2018 showed an increasing trend in hematopoietic cell transplants (HCT), especially allogeneic HCT. The main indications for HCT were acute leukemias and plasma cell disorders. The most commonly used donor types were HLA identical siblings and related mismatched/haploidentical donors.

BONE MARROW TRANSPLANTATION (2022)

添加到收藏夹

Article Hematology

One and a half million hematopoietic stem cell transplants: continuous and differential improvement in worldwide access with the use of non-identical family donors

Dietger Niederwieser et al.

Summary: The Worldwide Network of Blood and Marrow Transplantation promotes hematopoietic cell transplantation by evaluating activities through member societies, national registries, and individual centers. The number of HCT procedures is increasing globally, with narrowing gaps between regions.

HAEMATOLOGICA (2022)

添加到收藏夹

Article Hematology

Allogeneic hematopoietic cell transplantation with non-myeloablative conditioning for patients with hematologic malignancies improved outcomes over two decades

Jason P. Cooper et al.

Summary: Over the past 20 years, improvements in clinical practice have led to a reduction in morbidity and mortality in allogeneic hematopoietic cell transplantation. Comparing outcomes from different years, it was found that overall survival, progression-free survival, and non-relapse mortality have significantly improved.

HAEMATOLOGICA (2021)

添加到收藏夹

Review Hematology

Graft-versus-host disease prophylaxis: Pathophysiology-based review on current approaches and future directions

Nuria Martinez-Cibrian et al.

Summary: GvHD, a complication of transplantation, has seen advancements in prevention and treatment, yet challenges remain. Through ongoing research and clinical trials, efforts are being made to find more effective strategies to improve patient outcomes.

BLOOD REVIEWS (2021)

添加到收藏夹

Meeting Abstract Hematology

High Early Death Rates, Treatment Resistance and Short Survival of Black Adolescent and Young Adults (AYAs) with Acute Myeloid Leukemia (AML) (Alliance)

Karilyn Larkin et al.

BLOOD (2021)

添加到收藏夹

Review Oncology

Reduced Intensity Conditioning Followed by Allogeneic Hematopoietic Stem Cell Transplantation Is a Good Choice for Acute Myeloid Leukemia and Myelodysplastic Syndrome: A Meta-Analysis of Randomized Controlled Trials

Yanzhi Song et al.

Summary: Reduced intensity conditioning has similar overall survival and relapse incidence as myeloablative conditioning in AML and MDS patients. It significantly reduces non-relapse mortality compared to myeloablative conditioning.

FRONTIERS IN ONCOLOGY (2021)

添加到收藏夹

Article Oncology

Measurable residual disease status and outcome of transplant in acute myeloid leukemia in second complete remission: a study by the acute leukemia working party of the EBMT

Maria H. Gilleece et al.

Summary: This study evaluated the impact of MRD status at the time of HCT on outcomes for AML CR2 patients. It found that being MRD negative, having good-risk cytogenetics, and longer time from diagnosis to HCT were favorable factors for predicting relapse and leukemia-free survival. In-vivo T cell depletion was predictive of relapse.

BLOOD CANCER JOURNAL (2021)

添加到收藏夹

Review Immunology

GVHD Prophylaxis 2020

Mahasweta Gooptu et al.

Summary: GVHD, both acute and chronic, is a major complication of allogeneic transplantation, and its prevention is crucial for the success of transplants. Current standards revolve around calcineurin inhibitors, but promising translational advances targeting T-cell regulation and co-stimulatory pathways are emerging. These approaches are based on a pathophysiology perspective and show potential for transforming GVHD prophylaxis in the near future.

FRONTIERS IN IMMUNOLOGY (2021)

添加到收藏夹

Article Hematology

Allogeneic hematopoietic stem cell transplantation improves long-term outcome for relapsed AML patients across all ages: results from two East German Study Group Hematology and Oncology (OSHO) trials

Thomas Heinicke et al.

Summary: Relapse of acute leukemia is a common complication with uncertain outcomes, affecting both younger and older patients. Factors such as hematopoietic cell transplantation and long-term remission are beneficial, while challenges remain in the treatment and prognosis of relapse.

ANNALS OF HEMATOLOGY (2021)

添加到收藏夹

Article Infectious Diseases

Efficacy and safety of isavuconazole compared with voriconazole as primary antifungal prophylaxis in allogeneic hematopoietic cell transplant recipients

Yael Bogler et al.

Summary: In the first three months after allogeneic hematopoietic cell transplant, isavuconazole was found to be safer and equally effective compared to voriconazole, with lower rates of hepatotoxicity, similar rates of fungal infections, and all-cause mortality.

MEDICAL MYCOLOGY (2021)

添加到收藏夹

Review Oncology

The long shadow of socioeconomic deprivation over the modern management of acute myeloid leukemia: time to unravel the challenges

M. Joseph John et al.

Summary: This article illustrates the impact of socioeconomic and anthropogeographical constraints on the optimal management of acute myeloid leukemia in different healthcare systems through case studies, highlighting the importance of developing targeted socioeconomic interventions to address the changing landscape of AML therapeutics and avoid exacerbating outcome disparities among patients with biologically similar diseases.

BLOOD CANCER JOURNAL (2021)

添加到收藏夹

Letter Hematology

Long-term follow-up of a trial comparing post-remission treatment with autologous or allogeneic bone marrow transplantation or intensive chemotherapy in younger acute myeloid leukemia patients

Frederic Baron et al.

HAEMATOLOGICA (2020)

添加到收藏夹

Article Hematology

Autologous hematopoietic cell transplantation for acute myeloid leukemia in adults: 25 years of experience in Japan

Masamitsu Yanada et al.

INTERNATIONAL JOURNAL OF HEMATOLOGY (2020)

添加到收藏夹

Article Biophysics

The EBMT activity survey on hematopoietic-cell transplantation and cellular therapy 2018: CAR-T's come into focus

Jakob R. Passweg et al.

BONE MARROW TRANSPLANTATION (2020)

添加到收藏夹

Article Hematology

Treosulfan or busulfan plus fludarabine as conditioning treatment before allogeneic haemopoietic stem cell transplantation for older patients with acute myeloid leukaemia or myelodysplastic syndrome (MC-FludT.14/L): a randomised, non-inferiority, phase 3 trial

Dietrich Wilhelm Beelen et al.

LANCET HAEMATOLOGY (2020)

添加到收藏夹

Article Oncology

The global burden and attributable risk factor analysis of acute myeloid leukemia in 195 countries and territories from 1990 to 2017: estimates based on the global burden of disease study 2017

Ming Yi et al.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)

添加到收藏夹

Article Oncology

Leukemia incidence trends at the global, regional, and national level between 1990 and 2017

Ying Dong et al.

EXPERIMENTAL HEMATOLOGY & ONCOLOGY (2020)

添加到收藏夹

Article Biophysics

Myeloablative and reduced-intensity conditioning in HLA-haploidentical peripheral blood stem cell transplantation using post-transplant cyclophosphamide

Junichi Sugita et al.

BONE MARROW TRANSPLANTATION (2019)

添加到收藏夹

Article Biophysics

Narrowing the gap for hematopoietic stem cell transplantation in the East-Mediterranean/African region: comparison with global HSCT indications and trends

Helen Baldomero et al.

BONE MARROW TRANSPLANTATION (2019)

添加到收藏夹

Review Biophysics

Worldwide Network for Blood & Marrow Transplantation (WBMT) special article, challenges facing emerging alternate donor registries

Mahmoud Aljurf et al.

BONE MARROW TRANSPLANTATION (2019)

添加到收藏夹

Article

Autologous Hematopoietic Stem Cell Transplantation in Acute Myelogenous Leukemia

Yuanqi Zhao et al.

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)

添加到收藏夹

Article Oncology

Allogeneic hematopoietic cell transplantation compared to chemotherapy consolidation in older acute myeloid leukemia (AML) patients 60-75 years in first complete remission (CR1): an alliance (A151509), SWOG, ECOG-ACRIN, and CIBMTR study

Celalettin Ustun et al.

LEUKEMIA (2019)

添加到收藏夹

Review Hematology

Autologous hematopoietic cell transplantation for AML in first remission - An abandoned practice or promising approach?

Moshe Yeshurun et al.

SEMINARS IN HEMATOLOGY (2019)

添加到收藏夹

Article Hematology

Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients Age >69 Years with Acute Myelogenous Leukemia: On Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Olle Ringden et al.

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)

添加到收藏夹

Article Hematology

Prospective randomization of post-remission therapy comparing autologous peripheral blood stem cell transplantation versus high-dose cytarabine consolidation for acute myelogenous leukemia in first remission

Toshihiro Miyamoto et al.

INTERNATIONAL JOURNAL OF HEMATOLOGY (2018)

添加到收藏夹

Article Oncology

Decreased Early Mortality Associated With the Treatment of Acute Myeloid Leukemia at National Cancer Institute-Designated Cancer Centers in California

Gwendolyn Ho et al.

CANCER (2018)

添加到收藏夹

Meeting Abstract Hematology

Outcome of Patients with Acute Myeloid Leukemia (AML) Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) Beyond First Complete Remission (CR1)

Georg Evers et al.

BLOOD (2018)

添加到收藏夹

Review Hematology

Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel

Hartmut Doehner et al.

BLOOD (2017)

添加到收藏夹

Letter Oncology

Prevalence and characteristics of survivors from acute myeloid leukemia in Sweden

G. Juliusson et al.

LEUKEMIA (2017)

添加到收藏夹

Article Oncology

Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes

Bart L. Scott et al.

JOURNAL OF CLINICAL ONCOLOGY (2017)

添加到收藏夹

Article Biophysics

Latin America: the next region for haematopoietic transplant progress

G. Jaimovich et al.

BONE MARROW TRANSPLANTATION (2017)

添加到收藏夹

Article Oncology

Colorectal cancer statistics, 2017

Rebecca L. Siegel et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2017)

添加到收藏夹

Review Hematology

Hematopoietic stem cell transplantation for patients with AML in first complete remission

Jan J. Cornelissen et al.

BLOOD (2016)

添加到收藏夹

Review Hematology

On Modeling Human Leukocyte Antigen-Identical Sibling Match Probability for Allogeneic Hematopoietic Cell Transplantation: Estimating the Need for an Unrelated Donor Source

Kelsey Besse et al.

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2016)

添加到收藏夹

Article Biophysics

Hematopoietic stem cell transplantation activity worldwide in 2012 and a SWOT analysis of the Worldwide Network for Blood and Marrow Transplantation Group including the global survey

D. Niederwieser et al.

BONE MARROW TRANSPLANTATION (2016)

添加到收藏夹

Article Medicine, General & Internal

Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial

Johan A. Maertens et al.

LANCET (2016)

添加到收藏夹

Article Medicine, General & Internal

Genomic Classification and Prognosis in Acute Myeloid Leukemia

Elli Papaemmanuil et al.

NEW ENGLAND JOURNAL OF MEDICINE (2016)

添加到收藏夹

Article Oncology

Comparison of Patient-Reported Outcomes in 5-Year Survivors Who Received Bone Marrowvs Peripheral Blood Unrelated Donor Transplantation Long-term Follow-up of a Randomized Clinical Trial

Stephanie J. Lee et al.

JAMA ONCOLOGY (2016)

添加到收藏夹

Article Hematology

One million haemopoietic stem-cell transplants: a retrospective observational study

Alois Gratwohl et al.

LANCET HAEMATOLOGY (2015)

添加到收藏夹

Article Oncology

Comparative therapeutic value of post-remission approaches in patients with acute myeloid leukemia aged 40-60 years

J. J. Cornelissen et al.

LEUKEMIA (2015)

添加到收藏夹

Article Medicine, General & Internal

HLA Match Likelihoods for Hematopoietic Stem-Cell Grafts in the US Registry

Loren Gragert et al.

NEW ENGLAND JOURNAL OF MEDICINE (2014)

添加到收藏夹

Article Hematology

Race and ethnicity in decisions about unrelated hematopoietic stem cell donation

Galen E. Switzer et al.

BLOOD (2013)

添加到收藏夹

Article Hematology

Economics of hematopoietic cell transplantation

Nandita Khera et al.

BLOOD (2012)

添加到收藏夹

Article Medicine, General & Internal

Long-term Outcomes Among Older Patients Following Nonmyeloablative Conditioning and Allogeneic Hematopoietic Cell Transplantation for Advanced Hematologic Malignancies

Mohamed L. Sorror et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)

添加到收藏夹

Review Hematology

How I treat cytomegalovirus in hematopoietic cell transplant recipients

Michael Boeckh et al.

BLOOD (2009)

添加到收藏夹

Article Biophysics

Special issues related to hematopoietic SCT in the Eastern Mediterranean region and the first regional activity report

M. D. Aljurf et al.

BONE MARROW TRANSPLANTATION (2009)

添加到收藏夹

Article Medicine, General & Internal

Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease

Andrew J. Ullmann et al.

NEW ENGLAND JOURNAL OF MEDICINE (2007)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.